Gabelli Funds’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-772,710
Closed -$16.1M 1387
2022
Q3
$16.1M Buy
772,710
+471,968
+157% +$9.83M 0.13% 209
2022
Q2
$6.24M Buy
300,742
+194,174
+182% +$3.46M 0.05% 416
2022
Q1
$1.79M Buy
106,568
+22,268
+26% +$389K 0.01% 749
2021
Q4
$1.68M Buy
84,300
+1,050
+1% +$19.8K 0.01% 768
2021
Q3
$1.51M Buy
83,250
+6,500
+8% +$149K 0.01% 801
2021
Q2
$2.07M Hold
76,750
0.01% 744
2021
Q1
$2.3M Hold
76,750
0.02% 696
2020
Q4
$2.21M Sell
76,750
-19,500
-20% -$526K 0.02% 678
2020
Q3
$2.35M Sell
96,250
-6,000
-6% -$129K 0.02% 637
2020
Q2
$1.83M Sell
102,250
-31,500
-24% -$414K 0.01% 678
2020
Q1
$1.09M Sell
133,750
-136,650
-51% -$1.56M 0.01% 763
2019
Q4
$3.57M Sell
270,400
-159,900
-37% -$1.94M 0.02% 600
2019
Q3
$5.12M Buy
430,300
+128,800
+43% +$2.38M 0.03% 506
2019
Q2
$7.38M Buy
301,500
+99,510
+49% +$2.87M 0.05% 416
2019
Q1
$6.43M Buy
+201,990
New +$7.17M 0.04% 457

Other funds holding CVET

Gabelli Funds's CVET Position: Q4 2022 in Review

Gabelli Funds sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 772,710 shares — an estimated $16.1M sold.

Gabelli Funds first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $16.1M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Gabelli Funds reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 772,710 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $16.1M.
  • Gabelli Funds first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Gabelli Funds's Covetrus, Inc. Common Stock position peaked at $16.1M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.